about us

Dark blue outlined leaf like shapes

our philosophy

Between rising sea levels, increasing global weather catastrophes and ever-more dooming climate prognoses, it’s clear that we can’t keep going on with business as usual. For the sake of the future of planet earth, we need to act now.

At FS Investment it’s our goal to take action against climate change and the dramatic global decline on biodiversity by funding and mentoring early-stage environmental and Life Science startups and business ideas that are working towards creating a positive impact on the planet.

As business owners in the Life Sciences with over 60 years of combined experience, we want to offer our expertise and guidance, as well as financial support. We’re happy to advise entrepreneurs with topics such as business proposals, financing, development strategy, general corporate governance, and HR. We love learning about innovative ways that entrepreneurs are approaching sustainable and socially responsible solutions and foster a mutual learning environment instead of a top-down approach.

Our core belief is that transitioning to sustainable industries and lifestyles are vital factors in solving our environmental challenges. We’re here to roll our sleeves up and make that happen.

who we are

Dr. Carmen Zirngibl, founder and managing partner of FS Life Science Investment GmbH

Dr. Carmen Zirngibl

Founder and Managing Partner

»Since my teenage years, I have been passionate about environmental protection and reversing climate change. I’m honored to be in a position to have gathered more than 30 years of business experience I can share with young companies who are creating businesses to further this cause. I believe in contributing to a sustainable future through supporting others and working together.«

Carmen’s expertise

Carmen founded DCZ Executive Search GmbH in 1997 in Düsseldorf, Germany, entering the market as the first consultancy specializing in recruiting for biotech companies.

In addition to her excellent track record in executive search consultancy dedicated to the life sciences, healthcare and technology-focused industries, Carmen displays an in-depth understanding of research and development in academia as well as in industry.

Carmen is the CEO of DCZ Executive Search, joined FS Life Science Investment as Managing Partner in 2012, and in 2017 joined the advisory board of BioEcho Life Sciences GmbH. In these roles, she offers consultancy on the topics of HR and sustainability.

Carmen has a background in natural sciences, including high-profile studies and research at the Universities of Oxford, Marburg and Regensburg.

Carmen is passionate about sustainability and environmental protection, and is an active supporter of ThankU.

Dr. Frank Schaefer, founder and managing partner of FS Life Science Investment GmbH

Dr. Frank Schäfer

Founder and Managing Partner

»As a successful entrepreneur and leader I’d like to pass on what I’ve learned and give forward to the next generation who are working to protect our planet through innovation. I believe that only by supporting these new ideas can we shift industries away from harming the environment and towards making a positive impact at scale.«

Frank’s expertise

Frank is co-founder and member of the board at BioEcho Life Sciences. Until recently, he was co-CEO of BioEcho responsible for Sales & Marketing, Business Development, Finance and HR.

Frank has 28 years of experience with biotech companies where he held R&D and General Management positions. He co-founded three companies and has profound hands-on knowledge in strategic development, fund-raising, and setting up start-up endeavors.

Frank spent 16 years in various functions in R&D at Qiagen, Germany, and 3 years with US-based Caris Life Sciences, a leading precision medicine service provider.

Frank also founded Cube Biotech, Germany-based protein service provider and is active as a Business Angel via FS Life Science Investment since 2012.

portfolio

Our current and previous investments.

Logo Bio Echo Life Sciences

BioEcho Life Sciences

Global biotech tools and genomic services company with labs and offices in Cologne, Germany, and Boston, MA, USA

  • Sustainability pioneer: introduced consideration of sustainability into the molecular biology sector and reduced 70% of plastic waste
  • 70 employees in 2022

products:

kits and services based on their new-to-the-world single-step nucleic acid extraction technologies that offer significant speed-up and simplification

markets:

pharma and biotech / molecular diagnostics / plant breeding / genomic research

status of investment:

exit

go to website
Logo Cube Biotech

Cube Biotech

Biotech tools and services company based in Monheim, Germany and Wayne, PA, USA

  • Supports the pharmaceutical and biotechnical community with technologies and techniques, for the full spectrum of protein research

products:

kits, membrane protein products and protein services

markets:

pharma / biotech

status of investment:

exit

go to website
Logo Plastic2Beans

Plastic2Beans

Distributor of maximum sustainable and fair-trade Ethiopean highlands coffee

  • Finalist of the Germany Sustainability Prize and winner of numerous sustainability awards
  • Build a plastic recycling system in Ethiopia

products:

speciality coffee sold in reusable glass containers to help reduce packaging waste

markets:

retail

status of investment:

active

go to website
Logo capacura: rise by lifting others

capacura

Impact investment organization based in Cologne, Germany

  • Investing in startups made easy and democratic through small investments.
  • 18 employees

products:

Small-scale investment products from 1000€

markets:

education / health / environmental protection

status of investment:

active

go to website

eco:fibr

Pulp production company based in Hannover, Germany

  • Use of crop waste (e. g., pineapple) to replace trees as the starting material for pulp (cellulose) for paper production
  • Energy-saving circular production process
  • High-quality products
  • 5 employees

products:

  • pulp (cellulose) for the paper industry
  • further products for use in the pharmaceutical industry (e. g., lignin, proteins)

markets:

paper industry / pharmaceutical & chemical materials

status of investment:

active

go to website

WM Therapeutics (WMT AG)

Pharmaceutical company based in Heidelberg, Germany

  • Discovery and development of novel cancer and inflammation therapies based on small molecules
  • Mode of action: interference with cancer cells’ Warburg metabolism in order to restore tumor accessibility for the body’s own immune system
  • Affordable therapies against a broad spectrum of cancers (focus on gastro-intestinal cancers, e. g. pancreatic carcinoma, and multiple melanoma) and inflammatory diseases
  • <20 employees

products:

  • small molecule-based cancer therapeutics
  • small-molecule anti-inflammatory drugs

markets:

pharma

status of investment:

active

go to website

Boomerang Systems

Logistics company based in Hamburg, Germany

  • High-quality bags and boxes made from recycled materials
  • >50-fold reusable
  • Return by folding and posting (regular mailbox)
  • Deposit return scheme
  • Development of software solutions to be integrated into customers’ online shops
  • <20 employees

products:

  • reusable bags and boxes for shipment of small goods in e-Commerce and intra-logistics
  • software systems for integration into online shops

markets:

retail (online shops)

status of investment:

active

go to website

Primogene GmbH

Biotechnology company based in Leipzig, Germany

  • Development of additives for infant nutrition that are identical to breastmilk components
  • Promoting a healthy gut microbiome and addressing neonatal challenges such as feeding intolerances
  • Final goal: nature-identical animal-free infant formula 
  • Strong patent portfolio
  • <10 employees

products:

  • small molecules and proteins as additives to infant formula
  • additives and services for other industries (e. g., cosmetics, pharma)

markets:

food (infant nutrition) | cosmetics | pharma

status of investment:

active

go to website

Ready to plant a new seed?